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Summary The purpose of this study was to determine whether power Doppler ultrasound techniques could be used to direct biopsies into
tumour regions with relatively low red blood cell flux, and therefore preferentially sample regions that were relatively hypoxic. Subcutaneous
9L glioma rat tumours were biopsied using power Doppler ultrasound guidance. Immunohistochemical detection of the 2-nitroimidazole EF5
was performed to determine the presence and level of hypoxia in the biopsy samples. Comparisons between the power Doppler-determined
red blood cell flux and EF5 binding were made. In seven out of eight tumours studied, power Doppler ultrasound allowed differentiation of a
relatively hypoxic region from a relatively oxic region by localizing relatively low vs high red blood cell flux areas respectively. In one of these
seven tumours, RBC flux was high in both biopsied sites and hypoxia was not present in either. In two of these seven tumours, hypoxia was
present in each biopsy and both of the red blood cell flux measurements were low. In the eighth tumour, both the EF5 binding and the red
blood cell flux measurements were low. In this tumour, low EF5 binding was due to the dominance of necrotic cells, which will not reduce or
bind EF5 in the biopsy specimen. Using EF5-binding techniques, we have confirmed that regions of relatively low red blood cell flux are more
hypoxic than those with relatively high red blood cell flux. Counterstaining specimens with haematoxylin and eosin allows differentiation of low
EF5-binding regions due to oxia vs necrosis. These methods have clinical implications for the expanded use of power Doppler ultrasound as
a means to direct tissue sampling when it is important to identify the presence of hypoxia.
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Heterogeneity is one ofthe most common and clinically important
characteristics of tumours. Heterogeneity has been categorized as
either clonal, related to genetic aspects of tumour biology, or
secular, related to microenvironmental aspects (Heppner, 1984;
Heppner and Miller, 1989). A majordeterminant ofsecular hetero-
geneity is the tumour vasculature. Because tumour blood vessels
cannot grow as rapidly as the neoplastic tissues, the resulting
vasculature is disorganized and inefficient. Elegant window
chamber studies by Secomb et al (1993) have demonstrated that
tumour vasculature is characterized by the presence of arteriove-
nous shunting, sinusoid formation, plasma flow in the absence of
red blood cell (RBC) flow and flow ofdeoxygenated RBCs. These
characteristics, interacting with the variable metabolic consump-
tion of tumour and host cells, result in the presence ofmicroenvi-
ronments that include hypoxia (Vaupel et al, 1989). Hypoxic
microenvironments have been shown to be associated with poor
prognosis and treatment response. For example, the presence of
hypoxia in human tumours, assessed using the Eppendorf polaro-
graphic needle electrode, has been correlated with metastasis in
soft tissue sarcomas (Brizel et al, 1996) and local-regional recur-
rence in cervical carcinoma after surgery or radiation therapy
(Hockel et al, 1996).
One of the difficulties in measuring tumour tissue oxygenation
is sampling error. This problem is particularly relevant to the
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accuracy of hypoxia determination using needle electrodes and
biopsy-based measurement techniques, including the Comet assay
(Olive et al, 1990) and nitroimidazole binding (Koch et al, 1995;
Evans et al, 1996). The presence ofhypoxia is an indicator ofpoor
prognosis and patients with hypoxic tumours require specialized,
aggressive and expensive therapy. Examples include treatment
with hypoxic cytotoxins (Lee et al, 1996), vasoactive agents in
combination with changes in radiation fractionation and inhaled
oxygen (ARCON; Rojas, 1992), radiation sensitizers (Huilgol et
al, 1996) and hyperthermia (Oleson, 1995). As inaccurate assess-
ments ofthe presence ofhypoxia would be very deleterious to the
patient, any technique that would aid accurate sampling ofhypoxic
regions should improve patient care. In this report, we suggest the
use of power Doppler ultrasound to augment the accuracy of
hypoxia assessment.
Power Doppler ultrasound has been described for use in clinical
medicine by Rubin et al (1994). The application of this technique
is primarily in the evaluation of blood flow. The hue and bright-
ness of the colour signal representing the power of the Doppler
spectrum is related to the number of RBCs, e.g. RBC flux,
producing the Doppler shift. This technique is well suited to
evaluate tumour blood flow because it is more sensitive to lower
velocity blood flow than colour Doppler techniques (Eriksson et
al, 1991). As hypoxia is primarily a result of low or ineffective
tumour blood flow (Vaupel et al, 1989), we hypothesized that
ultrasound Doppler techniques could be used to direct biopsies
into tumour regions with the lowest relative blood flow, and these
regions were likely to be relatively hypoxic.
We have investigated this hypothesis in the 9L glioma tumour
grown subcutaneously in Fischer rats. Using nitroimidazole-
binding techniques, specifically the 2-nitroimidazole EF5 with
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Figure 1 Ultrasound images of subcutaneous 9L glioma tumour no. 960216-1. (A) Grey scale image of tumour preceding biopsy. The tumour is approximately
2.5 cm in depth and heteroechoic in appearance. Deep in the tumour, thigh musculature and the femur (hypoechoic region) can be seen. (B) Power Doppler
image, superimposed over grey scale, prebiopsy tumour image. Vessels with hyperechoic characteristics on grey scale image (at approximately 2.2 cm depth)
can be seen as well as larger regions containing smaller, less well-defined regions of RBC flux (at approximately 1.0 cm depth). (C) Power Doppler image
superimposed over grey scale, post-biopsy tumour image. Note the visualization of biopsy tracks as a result of air remaining at the sites. (D) Prebiopsy digitized
image with the region of interest (ROI) of 20 mm length and the 2.5 mm width on each side of the biopsy track (final width 5 mm)
monoclonal antibody-based immunohistochemical detection
methods, we have confirmed that regions of relatively low RBC
flux are more hypoxic than those with high RBC flux. This obser-
vation has clinical implications for the expanded use of power
Doppler ultrasound as a relatively simple, inexpensive and
commonly available means to direct needle electrode measure-
ments and tissue sampling techniques for the identification of
tumour hypoxia.
MATERIALS AND METHODS
Animals and tumours
Tumours were grown from cells derived from the 9L rat glioma
(Leith et al, 1975; Wallen et al, 1980). These cells were originally
obtained from Dr KT Wheeler (Bowman Gray School of
Medicine, Winston Salem, NC, USA). All animal studies were
performed under the regulations provided by the University of
Pennsylvania Institutional Animal Care and Use Committee. 9L
tumours were grown by transferring 1-3 mg pieces oftumour into
the subcutaneous space overthe thigh musculature ofmale Fischer
rats weighing 200-250 g. All tumours used were of late passage
(> 6) which, based upon our previous studies, have a high
probability of containing radiobiologically significant hypoxia
[(Evans et al, 1996), other data not shown]. All tumours were
between 2 and 4 cm maximum diameter.
Ultrasound and Doppler studies
The hair overlying the tumour region was shaved and the rat was
positioned in sternal recumbency for ultrasound examination and
tumour biopsy. Tumour images were acquired using grey scale
imaging and power Doppler techniques on an ATL Ultramark
9HDI scanner (ATL, Bothell, WA, USA). The imaging was
performed using a 10-5 transducer. A low wall filter (less than
50-Hz) was used throughout the study to maximize visualization
oflow RBC flux.
Grey scale images were initially made to determine the extent
and patterns of echogenic heterogeneity and, when possible, to
identify regions that were likely to be necrotic. Colour and power
Doppler studies were then performed to map RBC flux. Two or
three ultrasound Doppler-guided biopsies were made in each
tumour, with the emphasis on directing biopsies to regions with
the relatively lowest vs highest RBC flux. Careful attention was
paid to using a large amount of ultrasound gel to couple the trans-
ducer to the tumour surface, and to avoid surface pressure that
could modify blood flow in the tumour. After studying three
tumours, it became apparent that the information obtained from
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Figure 2 EF5 binding in two core biopsy specimens from the 9L tumour
imaged in Figure 1. A is a biopsy from a region of relatively high, diffuse RBC
flux, whereas B represents a biopsy from the region of low RBC flux,
adjacent to the distinct blood vessel seen in Figure 1. Both sections are 4x
magnification and the photographs exposed for the same amount of time
regions that were immediately adjacent to the ultrasound trans-
ducer (to a depth of approximately 5 mm) did not reliably reflect
the presence or absence ofRBC flux. This conclusion was reached
because when the tumour was scanned from various directions
different assessments of flux were obtained from the regions that
were adjacent to the transducer. However, regions deeper than
5 mm from the transducer surface were consistent in their ultra-
sound Doppler characteristics. Use ofa tissue equivalent stand-off
was attempted but there was concern that the pressure from the
stand-off could modify blood flow. In addition, it was technically
impossible to direct accurately biopsies with the stand-offin place.
Therefore, biopsies obtained from the most superficial tumour
regions were not included in the analyses.
Images were recorded on tape and analysed by a computerized
method based on semi-automated vessel counting of the power
Doppler images. The videotaped images were digitized frame by
frame at 8-bit resolution using a frame grabber (Nuvista+,
Truevision, Indianapolis, IN, USA). For each tumour, three pre-
and three post-biopsy images weredigitized. Theregion ofinterest
(ROI) was identified on post-biopsy images, based upon the pres-
ence ofairin thebiopsy needle track. This ROI was then applied to
individual frames of corresponding prebiopsy images. The ROI
was a rectangle with a length of 20 mm and a width of2.5 mm on
each side of the biopsy track (final width 5 mm). Each ROI was
analysed for the area of flow by measuring the percentage (%)
coloured pixels. The coloured and grey scale pixels were identified
using the colour scale on the image frame. A detailed look-up table
(LUT) for colour was constructed by using the red-green-blue
(RGB) values ofthe colour bar on the image. Thepixels within the
ROI matching the RGB values of the LUT were counted as
coloured pixels. The ratio ofcoloured pixels to the total number of
pixels in the ROI was used to calculate percentage colour index
representing the area offlow.
EF5
A pentafluorinated derivative of etanidazole was synthesized by
Dr M Tracy and colleagues at Stanford Research International,
Palo Alto, CA, USA and is referred to as EF5 in this manuscript.
Monoclonal antibodies were made against radiochemically
produced adducts of EF5 and thiol-containing proteins, as
described previously (Lord et al, 1993). The antibodies used in the
present study are from a single hybridoma clone, designated as
ELK3-51. The monoclonal antibodies were conjugated with the
green-excited, orange-emitting fluorescent dye, Cy3 (Southwick et
al, 1990). This dye is available in an amine reactive form from
Amersham (Arlington Heights, IL, USA).
Hypoxic marker tumour biopsy studies
Tumour-bearing rats were given EF5 as an intravenous injection of
10 mm solution prepared in 0.9% saline. The mass of solution
administered was 1% ofthe animal's mass and the resulting equiv-
alent whole-body concentration was 100gM. Two hours after EF5
administration, the animal was anesthetized with intraperitoneal
injections of xylazine (1.3 mg kg-') and ketamine (140 mg kg-').
The hair overlying the tumour region was shaved and the animal
positioned for ultrasound examination and tumour biopsy. After
detailed ultrasound examination using grey scale and Doppler
techniques, two to three guided biopsies were obtained using a
14 G semiautomatic biopsy device (COOK Veterinary Products,
Bloomington, IA, USA). The resulting biopsies were between
5 and 15 mm in length and approximately 1.5 mm in diameter.
Biopsies were placed on moistened filter paper and rapidly frozen
by placing the filter paper on dry ice. The specific orientation of
each biopsy piece relative to the tumour surface was documented
by painting India ink on the portion of the biopsy that corre-
sponded to the most superficial tumour surface. After completion
of the biopsy procedure, the tumour was removed and weighed;
the portion of the tumour that contained the biopsy tracts was
frozen for further immunohistochemical and histopathological
analyses (Evans et al, 1995).
Whole tumour and core biopsy tissue sections were cut at 14gm
thickness using a Microm HM 505N cryostat and collected onto
poly-L-lysine-coated microscope slides, as described previously
(Evans et al, 1995). Briefly, the sections were fixed for 1 h at 4°C
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Figure 3 Line drawing of a haematoxylin and eosin section from whole tumour no. 960510-1 (left) and a biopsy specimen removed from that section
(drawing). The biopsy was divided in three equal parts, stacked one on top of another and sectioned in that manner. Shown on this diagram are the locations of
the photographs of Figure 4 (haematoxylin and eosin) and Figure 5 (EF5) below. 0, Figures 4 and 5A; IID, Figure 5B
Figure 4 Haematoxylin and eosin-stained section (10x) from the whole
tumour section of tumour no. 960510-1 shown in Figure 3. The area shown
represents the junction between viable (v), pyknotic (p) and necrotic (n)
tumour cells, similar to Figure 5A below
in 4% paraformaldehyde in Dulbecco's phosphate-buffered saline
(PBS), and rinsed twice in 1 x PBS. The tissue sections were then
blocked against non-specific binding at 40C overnight. After
removing the blocking solution, the slides were rinsed and ELK3-
51 antibody conjugated to Cy-3 was added (75 ,ug m-') for4-6 h at
40C. The slides were rinsed three more times and stored in Ix PBS
with 1% paraformaldehyde until photographed, usually within
three days. At each step, the exchange of solutions was accom-
plished by moving the tissue-containing slide from container to
container.
The tissue sections were analysed by measuring the fluores-
cence ofthe anti-EF5 monoclonal antibodies using a Zeiss fluores-
cence microscope fitted with a sensitive digital camera (Xillix,
Vancouver, BC, Canada). The biopsy sample sections were
imaged in their entirety and the whole tumour sections were
imaged using representative regions. After photography of EF5
binding, slides were stained with haematoxylin and eosin and eval-
uated under a light microscope for the identification and differenti-
ation ofviable tumour tissue from areas with pyknosis, necrosis or
acellularity.
Image analysis
To make the fluorescence evaluation as quantitative as possible
and to allow comparison from sample to sample, it was necessary
to measure the absolute fluorescence intensity of the regions of
interest. Day-to-day variations in the lamp intensity were
accounted for by filling the well ofa haemocytometer with a refer-
ence concentration ofCy3 dye (a concentration with absorbance of
0.42 at 549 nm), then imaging the haemocytometer well while
focusing on the gridlines. Variations in the fluorescence intensity
ofthe reference dye (typically a factor ofup to four during the life
of a quartz-halogen bulb) were then used to adjust the intensities
of the section images. In principle, this calibration would also
correct for variations in camera sensitivity, but we have no reason
to believe that camera sensitivity is not constant.
The section images were photographed so that the maximum
pixel intensities were within the linear range of the camera
(0-255). Two camera variables are set by the software; the camera
sensitivity (S; varying from 1/256 to 1/4048 in factors of 2) and
the camera exposure time (T; varying from less than 100 ms to
10 000 ms). Therefore, each pixel intensity is corrected by the
factor (S/4096 x 10 000/T). The corrected pixel intensities ofeach
image are divided by the median corrected pixel intensity of
the haemocytometer calibration standard to determine the final
fluorescence intensities.
Data analyses
Analyses of the relationship between the percentage of coloured
pixels and EF5 binding were performed. Because ofthe large stan-
dard deviations associated with the mean values (representing the
large contrast between oxic and hypoxic regions in the biopsy
specimens), the median EF5 values were correlated with the pixel
analyses.
RESULTS
Nine tumours in eight rats were studied with ultrasound and
biopsy (one rat had a bilobed tumour and each segment was
studied separately). The tumours ranged from 2 to 4 cm in
maximum diameter. In one tumour, the biopsies became damaged
during freezing and were not evaluated further. Biopsies from
eight tumours were analysed for median EF5 binding as a marker
of hypoxia and the percentage of coloured pixels as a measure of
regional tumour red blood cell flux.
Figure 1a demonstrates a prebiopsy grey scale image of a repre-
sentative subcutaneous 9L tumour (no. 960216-1). A 2.5-cm diam-
eter, heteroechoic tumour is seen. It is well defined by its
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Figure 5 EF5 stained sections (4x) from the whole tumour section (A) and
biopsy specimen (B) from tumour no. 960510-1 shown in Figure 3. In both
photomicrographs, a distinct pattern of hypoxia can be seen: there is a
central oxic region surrounding blood vessels (no EF5 binding) followed by
viable hypoxic cells and, in some areas, more distant necrotic cells. This
pattern was first described by Thomlinson and Gray (1955) in pathological
specimens of human bronchogenic carcinoma. A corresponds to
approximately the same region as Figure 4. In A and B, the absence of
binding in the areas marked 'n' are due to the presence of tumour cells that
are metabolically unable to bind EF5
hyperechoic capsule and lies adjacent to the underlying muscula-
ture. Figure lB and C was made using power ultrasound Doppler
techniques and these data are presented as regions offlow (colour)
superimposed on the appropriate prebiopsy (1B) or post-biopsy
(1C) greyscale images. The sites where two biopsy samples were
taken (no. 1 and no. 2) are seen in Figure IC. The deeper biopsy
(no. 1) was made several millimetres superficial to an ultrasono-
graphically identifiable blood vessel and the more superficial
biopsy (no. 2) was made in a region in which vascular flux is seen
over a larger and less well-defined tissue region. The hyperechoic
biopsy track can be reliably identified because ofthe airremaining
there. Figure ID represents the digitized IC image wherein, for
analysis of RBC flux, a 20 x 5 mm ROI was positioned over the
first biopsy site.
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Figure 6 Comparison of median EF5 binding and percentage of coloured
pixels in 16 biopsies from eight tumours. In seven of eight tumours studied,
power Doppler ultrasound allows differentiation of a relatively hypoxic region
from a relatively oxic region by localizing relatively low vs high red blood cell
flux areas respectively. - -0- -, 960216-1; - _U-, 960326-2; --A--,
960412-8; -x-, 960412-15; - -0--, 960510-1; -4--, 960510-2; -
960723-8; - -0- -, 960723-14
Figure 2A and B demonstrates the EF5 binding in the specimens
made in the sample sites described for Figure 1, above. Figure 2A
represents biopsy sample no. 2 with 26% coloured pixels and 19.3
median EF5 binding. Figure 2B is biopsy sample no. 1, which
contained a lower percentage of coloured pixels (11.3%) and
higher median EF5 binding (41.8).
Tumour no. 960510-1 was sectioned in detail and the whole
tumour sections from which the biopsies were removed were
stained for EF5 binding and restained with haematoxylin and
eosin. Figure 3 shows the gross appearance of one biopsy and the
whole tumour section from which it was removed. Portions ofthe
whole tumour section contain viable tumour cells (Figure 4) that
have a distinct pattern of hypoxia (Figure 5A); there are central
oxic regions (no EF5 binding) adjacent to regions of viable
hypoxic cells and in some areas, more distantnecrotic cells (Figure
5A and B). Blood vessels can be seen as dark circular regions in
the middle of the non-binding, oxic regions. Some aspects of the
tumourcontain necrotic regions (Figure 4) and EF5 binding cannot
be seen in these necrotic regions (Figure 5A and B). There is good
correspondence between the histological and immunohisto-
chemical appearance of the whole tumour section and the biopsy
section.
To determine whether Doppler ultrasound estimates of relative
low RBC flux could guide biopsies to regions corresponding to
hypoxia, a comparison was made between the percentage of
coloured pixels and median EF5 binding in eight tumours (Figure
6). In seven out ofeight tumours studied, the relationship between
the percentage of coloured pixels and median binding was nega-
tively correlated, as predicted. In the eighth tumour (no. 960510-1;
E]), a vertical slope characterized the relationship between binding
and flow. In this tumour, any possible correlation of increased
binding with decreased flow was masked by the presence of
necrosis (which does not bind EF5) in the low blood flow region.
The outcome of the assay was unclear in this tumour and the test
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failed because the presence of necrosis was not identified in the
grey scale ultrasound examination. The pattern ofEF5 binding, as
well as the percentage ofcolouredpixels in the two portions ofthe
bilobed tumour (no. 960510-1,2; l and *) were very different
from each other.
DISCUSSION
In recent years, the inter-relationship and clinical importance of
tumour clonal and secular heterogeneity has become increasingly
apparent. Genetic characteristics oftumours, such as up-regulation
of oncogenes (p53), gene products (VEGF) and metastatic poten-
tial have been associated with hypoxic tumour microenvironments
(Graeber et al, 1996; Mazure et al, 1996). The documentation that
hypoxia has a major impact on the biology, physiology, clinical
behaviour and treatment response ofhuman tumours has increased
in recent years. This has primarily been the result ofthe increased
ability to measure tissue hypoxia in situ using a variety of tech-
niques (Stone etal, 1993). Threemethodologies are in the forefront
of this effort: the Comet assay (Olive et al, 1990; 1993; 1994),
needle electrode measurements (Gatenby et al, 1988; Hockel et al,
1991; Brizel et al, 1996) and 2-nitroimidazole-binding techniques
(Hodgkiss et al, 1991; Cline et al, 1994; Evans etal, 1995; Koch et
al, 1995). Recent studies using the Eppendorf needle electrode in
humans, have documented the association of hypoxia with local
recurrence ofcervical carcinoma after surgery or radiation therapy
(Hockel etal, 1996) and metastasis ofsoft tissue sarcoma(Brizel et
al, 1-996). Studies in rodents usingbinding ofthe 2-nitroimidazole,
EF5, with monoclonal antibody detection have demonstrated the
close correlation of binding with radiation response (Evans et al,
1996; Woods et al, 1996) and the response to drug therapies that
modify tissue oxygen content (Lee et al, 1996).
Power Doppler ultrasound studies were proposed herein
because of the expected relationship between tissue oxygenation
and tumour blood flow. Previous studies in non-neoplastic
diseases of muscle (Newman et al, 1994) and kidney (Bude et al,
1994) have supported the notion that power Doppler ultrasonog-
raphy facilitates the evaluation of tissue perfusion. The current
applications of ultrasound in the field of oncology are limited to
tumour detection and staging [for example, see (Lindmark et al,
1992)] and to aid the placement of biopsies into regions of
abnormal grey scale echogenicity [for examples, see (Fomage et
al, 1992; Parker et al, 1993; McCombs et al, 1995)]. Few studies
have been performed that are directed toward the use of Doppler
ultrasoundtechniques to evaluate relative blood flow in cancers. In
a recentstudy ofirradiated rectal cancers, theultrasonographic and
colour Doppler flow imaging alterations observed within irradi-
ated rectal cancer correlated with changes ofpost-radiation oblit-
erans vasculitis (Alexander et al, 1996). We were unable to find
any previous studies that used Doppler techniques to assess the
relative presence and distribution ofhypoxia in tumours.
The aims ofthe studies herein were to determine whether ultra-
sound, an easily available, inexpensive and non-invasive imaging
technique, could be used to direct biopsies into regions in which
there was minimal blood flow and, therefore, hypoxia. There was
no expectation that ultrasound-based endpoints would correlate
directly with tumour hypoxia because it is clear, based upon
physiological principles, that red blood cell flux is only one of
several parameters that influence tissue oxygenation; parameters
including tissue respiration rate, blood oxygen carrying capacity,
haematocrit and microscopic blood flow distributions cannot be
accounted for in the ultrasound images. We have previously shown
that EF5 binding does correlate with tumourhypoxia and radiation
resistance (Evans et al, 1995). It was therefore hypothesized that
relative variations in the percentage of coloured pixels would
predict variations in EF5 binding in individual tumours. This
hypothesis is confirmed by the data shown in Figure 6. The
optimal relationship between the measured parameters of blood
flow (the percentage ofcoloured pixels on power Doppler studies)
and hypoxia (median EF5 binding) would be ahigh negative corre-
lation; herein seven out of eight tumours studied showed this
optimal relationship (Figure 6). It is notpossible from these data to
be certain that the specimen obtained in this manner was the most
hypoxic tumour region. However, based upon the comparison of
the biopsies to the whole specimen in one tumour (Figure 5), the
biopsy samples reflect the distribution ofhypoxia in the rest ofthe
tumour. Based upon our previous studies (Evans et al, 1996), the
radiation response in the 9L tumour is based upon the presence of
moderately, not severely hypoxic tumour cells. Whether this
holds true in human tumours remains to be seen. However, this is
likely because severely hypoxic tumour cells are unlikely to be
clonogenic.
Despite the confirmation ofourhypothesis, there is clearly more
room for technique improvement and further development. For
example, the transducer used in the present study was relatively
large in size, intended for species larger than rats. More accurate
information may be obtained with the use of a smaller and more
sensitive transducer or performing studies in dogs and cats with
spontaneous tumours, or humans. Similarly, we have not opti-
mized the machine settings for tumour measurements. Instead, we
chose to use a constant setting ofthe ultrasound machine based on
normal tissue applications. We will be investigating these aspects
of technique improvement using models in which absolute blood
flow can be determined independently, e.g. a tissue isolated
tumour model (Evans et al, 1995). In addition, we have not quanti-
tated the effects of intratumoral blood flow heterogeneity on the
sensitivity and specificity of the ultrasound images. It is probable
that a number ofblood cell scatterers and velocities are below the
threshold necessary to be detected using the power Doppler tech-
nique and we may require the use ofcontrast agents to enhance the
detection oflowest flow regions (Forsberg et al, 1995; Sehgal et al,
1995). These agents are designed to increase the number of scat-
terers in the vessels, increasing Doppler sensitivity to flow.
In the tumours studied herein, several regions of several colour
Doppler images contained no coloured pixels. Biopsies from these
areas consistently showed high EF5 binding and in one tumour,
necrosis. The highest level of EF5 binding was found in a biopsy
with 12% coloured pixels (tumour 960216-1; 0 Figure 6).
Physiologically, this may reflect blood flow in long vessels
carrying primarily deoxygenated blood (Secomb et al, 1993).
Alternatively, the respiration rate or tissue cellularity of this
tumour may have been higher than in other specimens. Inverse
arguments may be made for the finding of relatively low EF5
binding and low fractional coloured pixels in biopsies from
960412-8 and 960723-8 (A, A Figure 6). In future studies we will
apply more sophisticated analysis methods to the EF5-binding
assay as 'median' binding may be inferior to endpoints such as
threshold values or assessments ofheterogeneity.
To summarize, we believe that the use of ultrasound guidance
for the selection of regions of relatively low flow and relatively
low tissue oxygenation is a promising new technique to augment
the sampling ofhypoxic tumours. It should be useful for any ofthe
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oxygen detection methods currently being developed that rely on
sampling techniques (i.e. Comet assay, needle electrode measure-
ment, nitroimidazole binding). The use of ultrasound contrast
agents and harmonic imaging (Burns 1996) are areas of current
investigation and may refine these applications. A human clinical
trial of the use of EF5, including ultrasound guidance of biopsies,
is being developed under the auspices and support of the National
Cancer Institute, Decision Network Committee.
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